Inovio Pharmaceuticals Inc INO:NASDAQ

RT Quote | Last NYSE Arca, VOL From CTA | USD
after hours iconAfter Hours: Last | 04/09/21 EDT
8.71quote price arrow down-0.01 (-0.11%)
Volume
34,361
Close
8.72quote price arrow down-0.08 (-0.91%)
Volume
4,700,820
52 week range
6.88 - 33.79

...

Loading . . .
  • Open8.77
  • Day High8.89
  • Day Low8.64
  • Prev Close8.80
  • 52 Week High33.79
  • 52 Week High Date06/26/20
  • 52 Week Low6.88
  • 52 Week Low Date04/15/20

Key Stats

  • Market Cap1.816B
  • Shares Out208.31M
  • 10 Day Average Volume6.47M
  • Dividend-
  • Dividend Yield-
  • Beta0.76
  • YTD % Change-1.47

KEY STATS

  • Open8.77
  • Day High8.89
  • Day Low8.64
  • Prev Close8.80
  • 52 Week High33.79
  • 52 Week High Date06/26/20
  • 52 Week Low6.88
  • 52 Week Low Date04/15/20
  • Market Cap1.816B
  • Shares Out208.31M
  • 10 Day Average Volume6.47M
  • Dividend-
  • Dividend Yield-
  • Beta0.76
  • YTD % Change-1.47

RATIOS/PROFITABILITY

  • EPS (TTM)-1.12
  • P/E (TTM)-7.82
  • Fwd P/E (NTM)-14.27
  • EBITDA (MRQ)-120.496M
  • ROE (MRQ)-71.64%
  • Revenue (MRQ)7.41M
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-2,197.89%
  • Debt To Equity (MRQ)4.05%

EVENTS

  • Earnings Date05/10/2021
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest From Inovio Pharmaceuticals Inc

Profile

MORE
Inovio Pharmaceuticals, Inc. (Inovio) is a late-stage biotechnology company, which is involved in developing deoxyribonucleic acid (DNA) immunotherapies and vaccines focused on treating and preventing cancers and infectious diseases. The Company's DNA-based immunotherapies, in combination with its electroporation delivery devices, generates immune responses, in particular T cells, in the body to fight target diseases. It has completed, current or planned clinical programs of...
Simon Benito
Chairman
Jong Kim Ph.D.
Chief Executive Officer
Jacqueline Elizabeth Shea Ph.D.
Chief Operating Officer
Peter Kies
Chief Financial Officer
Address
6769 Mesa Ridge Rd
San Diego, CA
92121-2995
United States

Top Peers

SYMBOLLASTCHG%CHG
ZNTL
Zentalis Pharmaceuticals Inc
37.41-5.05-11.89%
BCRX
BioCryst Pharmaceuticals Inc
10.21-0.19-1.83%
FPRX
Five Prime Therapeutics Inc
37.94+0.05+0.13%
MDGL
Madrigal Pharmaceuticals Inc
117.02+0.43+0.37%
CYDY
Cytodyn Inc
3.13+0.04+1.16%